Annika Espander Jansson, a veteran equity analyst and private banker, has been appointed non-executive director of the Danish antibody company Symphogen A/S. Ms Jansson is the founder and chief executive of Asperia, a strategic and business advisory firm. Previously she was global head of private banking at Handelsbanken and before that, managing partner at Catella Healthcare, a venture capital concern. Ms Jansson holds a PhD from the University of Gothenburg.
Symphogen announced the appointment on 20 December 2013.
Copyright 2013 Evernow Publishing Ltd